India Performs First Dual-Console Robotic Heart Bypass Surgery

By The Indus Pulse Editorial Team3 min read

Surgeons at Medanta Hospital in Gurugram completed a global first on November 18, 2026: a five-arm, dual-console robotic beating-heart Totally Endoscopic Coronary Artery Bypass (TECAB) surgery performed with India's indigenous SSI Mantra Surgical Robotic System, according to LiveMint. Dr Nitin Kumar Rajput of Medanta and Dr Lalit Malik of Manipal Hospital, Jaipur led the operation under the supervision of SS Innovations International founder, chairman, and CEO Dr Sudhir Srivastava, operating simultaneously from two separate consoles, LiveMint reported.

Surgical Setup and Recovery

The surgical team used all five robotic arms of the SSI Mantra alongside a heart stabilisation system to keep the target area steady while the heart continued beating, avoiding both a breastbone incision and a heart-lung machine, according to LiveMint and Firstpost. Medanta reported that the patient's recovery over 15 days was encouraging, though further clinical experience will be needed to establish long-term outcomes, LiveMint and Firstpost reported. Approximately 1,500 physicians have been trained on the SSi Mantra, according to globenewswire.com. The SSi Mantra has been utilized to perform over 170 different types of surgical procedures, according to globenewswire.com.

Medanta Chairman and Managing Director Dr Naresh Trehan said the milestone reflected the hospital's focus on surgical innovation and showed how robotic surgery can make complex cardiac care less invasive, while Dr Malik said the dual-console setup and five-arm configuration met the procedure's demands, according to LiveMint. Dr Srivastava said the operation aligned with SS Innovations' 'Make in India, for the World' vision and its goal of making robotic surgery more affordable and accessible, LiveMint reported. According to Dr. Sudhir Srivastava, dual-console robotic surgery does not cost anything additional to the patient, and the technology could potentially reduce hospital recovery time from 10 days to five days, enabling hospitals to treat more patients.

SSI Mantra Platform Details

Firstpost noted that SS Innovations International is headquartered in India, incorporated in the United States, and trades on Nasdaq as SSII. Developed as a modular platform supporting three to five robotic arms, the SSI Mantra includes a 23-inch patient touchscreen, a 32-inch 3D 4K monitor, an open-faced surgeon command centre, a Vision Cart for the operating team, and more than 40 types of endo-surgical instruments, Firstpost and News9live reported. The SSI Mantra platform costs about ₹5 crore, according to thehindubusinessline.com.

Background

Conventional imported robotic systems cost about ₹15 crore, according to thehindubusinessline.com.

SS Innovations expects the U.S. Food and Drug Administration to complete its review of the Company's 510(k) premarket notification for the SSi Mantra by the end of Q1 2027 and believes European Union CE marking certification can be obtained by the end of 2026, according to U.S. Securities and Exchange Commission (EDGAR).

Spotted an error in this article? Tell us and we will check it.